IRCT20201108049311N7招募中3 期
Effect of mesenchymal stem cells derived from the placenta and their secretome for the treatment of GVHD: A triple-blinded randomized clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16 years 至 50 years（—）
- 性别
- All
入选标准
- •Patients with acute GVHD with fever and requiring hospitalization
排除标准
- •Patients with sepsis
研究者
相似试验
终止
2 期
Intra-articular mesenchymal stem cell injections following arthroscopic microfracture versus arthroscopic microfracture alone for knee cartilage defects: a pilot randomised controlled trialACTRN12614000812695Magellan Stem Cells40
进行中（未招募）
不适用
Application of Mesenchymal Stem Cells and full of plasma in the management of the burn wound in patients with large burn injury - Stem CellsEUCTR2012-001596-36-ESMIGUEL CASARES FERNÁNDEZ-ALVÉS
招募中
2 期
Cotransplantation of mesenchymal stem cells with nonmyeloablative haploidentical peripheral blood stem cells without T cells deleted for high-risk acute leukemia: to reduce the severity of graft versus host disease and relapseHigh-risk acute leukemia patientsCancer - Leukaemia - Acute leukaemiaACTRN12608000129381Huisheng Ai40
招募中
1 期
Evaluation the efficacy of stem cells condition medium on hair transplantation outcomeHair loss.Nonscarring hair loss, unspecifiedL65.9IRCT20200127046282N18Skin and Stem cell Research Center of Tehran University of Medical Sciences30
进行中（未招募）
1 期
Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress SyndromeModerate to severe SARS-Cov-2 related acute respiratory distress syndromeMedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestationsEUCTR2020-002772-12-FRCHRU NANCY30